Achieving and maintaining a healthy weight is one of the most powerful steps you can take for your overall wellbeing and your aesthetic outcomes. At Dr Sanjog Sharma's practice, we offer medically supervised weight management using the latest evidence-based treatments, including GLP-1 receptor agonist medications, tailored to your individual physiology, lifestyle, and goals. Whether you are preparing for a cosmetic procedure, recovering from one, or simply committed to a healthier version of yourself, our programme provides the clinical support you need to succeed.
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that have revolutionised the medical management of obesity. They work by mimicking a naturally occurring gut hormone that regulates appetite, slows gastric emptying, and signals satiety to the brain — helping you feel fuller for longer and significantly reducing caloric intake. These medications are not stimulants, are not habit-forming, and are backed by some of the most robust clinical trial data ever produced in obesity medicine. They work by suppressing appetite through hypothalamic receptors, delaying gastric emptying to prolong fullness, stabilising blood glucose by stimulating insulin release, and reducing the brain's reward response to food — often described by patients as silencing "food noise."
Dr Sanjog evaluates each patient individually and recommends the most appropriate medication based on your medical history, weight loss goals, and response to treatment.

You have type 2 diabetes or pre-diabetes and want to address both metabolic health and weight simultaneously.
A thorough consultation with Dr Sanjog will determine whether this treatment is appropriate for you and identify any potential contraindications specific to your medical history.
Please reach us at san.86.jog@gmail.com if you cannot find an answer to your question.
Yes. Semaglutide and tirzepatide have been studied in large-scale clinical trials involving tens of thousands of patients and are approved by major regulatory bodies including the US FDA, European EMA, and health authorities across Asia and the Middle East. Like all medications, they have a side effect profile that is reviewed and monitored during your programme.
Weight regain can occur after stopping GLP-1 medications, as obesity is a chronic condition with a biological basis. This is why our programme includes a long-term lifestyle and maintenance plan. Some patients transition to a lower maintenance dose; others are able to maintain their results through sustainable dietary and activity habits established during treatment.
Most patients notice reduced appetite within the first 1-2 weeks. Measurable weight loss typically begins within the first month and becomes more significant as the dose is titrated upward over 8-20 weeks depending on the medication. Average weight loss results range from 15-22% of body weight over 12-18 months.
GLP-1 medications are prescription treatments backed by robust randomised controlled trial data. They address the underlying hormonal and neurological drivers of appetite and weight — not willpower or motivation. This is clinical, evidence-based medicine, not a quick fix.
Yes. Dr Sanjog offers medical weight management consultations at both his Bangalore and Dubai practices. Specific medication availability may vary by country due to regulatory approvals — this will be discussed at your consultation.
No referral is required. You can book a consultation directly through our contact page or by calling the clinic. We offer consultations in Bangalore and Dubai.